Position:
CMO at AnnaMed, External Reviewer for Clinical Review Board at Millennium Pharmaceuticals, Consultant in oncology clinical trials and drug development at Dr. Robert Shepard, Medical Advisor at Cosmo Bioscience, CMO at Callisto Pharmaceuticals, Chief Medical Officer (CMO) at Callisto Pharmaceuticals
Location:
Raleigh-Durham, North Carolina Area
Work:
AnnaMed
- Houston, Texas Area since Nov 2012
-
CMO
Millennium Pharmaceuticals
- Cambridge, Massachusetts since Jul 2012
-
External Reviewer for Clinical Review Board
Dr. Robert Shepard
since Jan 2011
-
Consultant in oncology clinical trials and drug development
Cosmo Bioscience
since 2009
-
Medical Advisor
Callisto Pharmaceuticals
since Sep 2006
-
CMO
Callisto Pharmaceuticals
since Aug 2005
-
Chief Medical Officer (CMO)
Kendle International;
- Raleigh-Durham, North Carolina Area Jul 2011 - Aug 2011
-
Executive Director
Kendle International
- Raleigh-Durham, North Carolina Area Jan 2011 - Jul 2011
-
Consultant
Infinity Pharmaceuticals
2008 - Jun 2009
-
Global Medical Advisor
Infinity Pharmaceuticals
- Cambridge, Massachusetts Jun 2007 - Jun 2009
-
Full time contractor
PRA International
Apr 2007 - Mar 2009
-
Vice President, Scientific and Medical Affairs, Oncology, Hematology, Immunology
i3 Research
Feb 2005 - Jun 2007
-
Senior Director
AstraZeneca
Jan 2004 - Jan 2005
-
Director, Oncology Clinical Research and Development
University of Virginia Health System
Jun 2000 - Dec 2003
-
Assoc. Professor
Education:
Harvard Medical School 1978 - 1980
Postdoctoral fellowship, Pharmacology and Molecular Genetics
Duke University School of Medicine 1974 - 1978
MD, Medicine, Oncology, Immunology
Harvard University 1970 - 1974
AB, Biochemistry and Molecular Biophysics